by Maya Caldwell | Jul 13, 2018
According the US Food and Drug Administration (FDA) the number of new drug shortages in the US has jumped to 39 last year from 26 in the two prior years. While 39 is still significantly lower than the 250 registered in 2011, FDA acknowledges that the shortages “are...
by Maya Caldwell | Jun 26, 2018
The US Food and Drug Administration (FDA) released guidance on June 20, 2018 containing major revisions to its guidance on the clinical development of treatments for major depressive disorder (MDD), reported RAPS. The guidance is currently in draft form and contains...
by Maya Caldwell | Jun 21, 2018
There are roughly 135 genes associated with cardiomyopathy and congenital heart conditions that can potentially cause sudden death, reports FierceBiotech. However, variants of the genes can be classified a variety of ways. The two most common methods are either benign...
by Maya Caldwell | Jun 20, 2018
Join us at the DIA 2018 Global Annual Meeting in Boston from June 24-28. Gretchen Bowker, Chad Pannucci, Nancy Kant and Waylon Wright will all be in attendance from Pearl. Learn more about regulatory challenges, industry trends, evolving clinical research models,...
by Maya Caldwell | Jun 19, 2018
Gretchen Bowker (COO) and Diana Caldwell (CEO) at Pearl Pathways recently presented at IMDMC’s 2018 Reg 101. The workshop took place on Tuesday, June 12, 2018 from 8am to 5pm at the Montage in Indianapolis, Indiana. The workshop was designed for regulatory...
